A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
- 1 July 1996
- journal article
- Published by Springer Nature in Nature
- Vol. 382 (6589) , 319-324
- https://doi.org/10.1038/382319a0
Abstract
The adenoviral oncoprotein E1A induces progression through the cell cycle by binding to the products of the p300/CBP and retinoblastoma gene families. A new cellular p300/CBP-associated factor (P/CAF) having intrinsic histone acetylase activity has been identified that competes with E1A. Exogenous expression of P/CAF in HeLa cells inhibits cell-cycle progression and counteracts the mitogenic activity of E1A. E1A disturbs the normal cellular interaction between p300/CBP and its associated histone acetylase.Keywords
This publication has 33 references indexed in Scilit:
- CBP as a transcriptional coactivator of c-Myb.Genes & Development, 1996
- Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.Genes & Development, 1995
- A family of transcriptional adaptor proteins targeted by the E1A oncoproteinNature, 1995
- Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBPNature, 1995
- Nuclear protein CBP is a coactivator for the transcription factor CREBNature, 1994
- Activation of cAMP and mitogen responsive genes relies on a common nuclear factorNature, 1994
- E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivatorsCell, 1994
- Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.Genes & Development, 1994
- Phosphorylated CREB binds specifically to the nuclear protein CBPNature, 1993
- DNA tumor virus transforming proteins and the cell cycleCurrent Opinion in Genetics & Development, 1993